Passage Bio Appoints Maxine Gowen, Ph.D. to Board of Directors
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Passage Bio Appoints Maxine Gowen, Ph.D. to Board of Directors Passage BioFebruary 19, 2021 GMT PHILADELPHIA, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system (CNS) disorders, today announced the appointment of Maxine Gowen, Ph.D., to its board of directors, effective Feb. 18. Dr. Gowen is chief executive officer of Tamuro Bio, a post that she has held since July 2...